T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.6B |
| 2 |
Verizon
VZ
|
+$1.3B |
| 3 |
US Bancorp
USB
|
+$1.26B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.26B |
| 5 |
Lam Research
LRCX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.33B |
| 2 |
Tesla
TSLA
|
+$5.64B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$4.91B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.7% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.71% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Sarepta Therapeutics
SRPT
$1.95B
| $108M | 0.02% |
836,693
-382,178
| -31% | -$44.3M |
|
477
KT
KT
$9.03B
| $108M | 0.02% |
8,016,938
+162,157
| +2% | +$2.16M |
|
478
EastGroup Properties
EGP
$11B
| $107M | 0.02% |
719,386
+3,142
| +0.4% | +$474K |
|
479
Exelixis
EXEL
$12.5B
| $106M | 0.02% |
6,627,890
-1,395,152
| -17% | -$22.8M |
|
|
BNY
480
Bank of New York Mellon
BNY
$110B
| $106M | 0.02% |
2,331,190
-896,271
| -28% | -$38.4M |
|
481
Paychex
PAYX
$44.6B
| $106M | 0.02% |
916,473
+40,488
| +5% | +$4.74M |
|
482
Airbnb
ABNB
$111B
| $105M | 0.02% |
1,231,028
-144,505
| -11% | -$14.6M |
|
483
Assurant
AIZ
$13.9B
| $105M | 0.02% |
839,929
-72,473
| -8% | -$9.65M |
|
484
Martin Marietta Materials
MLM
$32.7B
| $105M | 0.02% |
309,521
-11,691
| -4% | -$3.99M |
|
|
COUP
485
DELISTED
Coupa Software Incorporated
COUP
| $104M | 0.02% |
1,312,868
-932,988
| -42% | -$55.8M |
|
|
ISEE
486
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $104M | 0.02% |
4,843,659
+1,397,305
| +41% | +$29.8M |
|
487
Fair Isaac
FICO
$24B
| $102M | 0.02% |
171,038
-14,684
| -8% | -$7.73M |
|
488
Denali Therapeutics
DNLI
$3.97B
| $101M | 0.02% |
3,648,888
+170,520
| +5% | +$5.07M |
|
|
ONC
489
BeOne Medicines Ltd
ONC
$40.3B
| $101M | 0.02% |
461,093
+13,676
| +3% | +$2.51M |
|
490
Gartner
IT
$11.6B
| $101M | 0.02% |
300,224
-20,991
| -7% | -$6.77M |
|
491
Affirm
AFRM
$26.2B
| $101M | 0.02% |
10,434,854
-113,695
| -1% | -$1.71M |
|
|
DICE
492
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $100M | 0.02% |
3,219,960
+666,503
| +26% | +$21.7M |
|
493
Vornado Realty Trust
VNO
$7.41B
| $100M | 0.02% |
4,809,659
-22,860
| -0.5% | -$523K |
|
494
Apple Hospitality REIT
APLE
$3.75B
| $100M | 0.02% |
6,336,143
-1,329,145
| -17% | -$21.4M |
|
495
Valero Energy
VLO
$98.7B
| $99.9M | 0.02% |
787,100
-100,478
| -11% | -$12.6M |
|
496
Lattice Semiconductor
LSCC
$18.2B
| $99.4M | 0.02% |
1,532,501
-46,985
| -3% | -$2.84M |
|
497
Banco Santander Chile
BSAC
$16.1B
| $99.3M | 0.02% |
6,267,896
+5,888,617
| +1,553% | +$87.7M |
|
498
Royalty Pharma
RPRX
$26.1B
| $99M | 0.02% |
2,504,532
+161,722
| +7% | +$6.75M |
|
499
AngloGold Ashanti
AU
$48.1B
| $98.6M | 0.02% |
5,077,773
-4,983,538
| -50% | -$81.8M |
|
|
ABCM
500
DELISTED
Abcam PLC
ABCM
| $98.2M | 0.02% |
+6,313,950
| New | +$98.6M |
|
Similar funds
T. Rowe Price Associates's Q4 2022 Portfolio in Review
As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
- T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
- T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
- T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
- T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
- T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
- T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.
Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.